Skip to main content


You are here

UM Ventures News

Baltimore Sun: University of Maryland School of Medicine Startup Acquired

Living Pharma Inc., a cancer treatment startup out of the University of Maryland School of Medicine, has been acquired by Lentigen Technology.

Lentigen Technology Inc., a Miltenyi Biotec Company, Acquires University of Maryland, Baltimore CAR-T Cell Start-Up, Living Pharma, Inc.

Lentigen Technology Inc., a subsidiary of Miltenyi Biotec GmbH, announced today its acquisition of immunotherapy start-up Living Pharma, Inc.

New Accelerator Seeks to Attract Connected Health and Fitness Startups from Across the Country to Baltimore

The 16-week M-1 Ventures program to provide dedicated startup support that facilitates the development of innovative health care solutions.

UMD, UMB Strategic Partnership Announces Expansion of Interdisciplinary Research at Cole Field House

The University of Maryland, College Park and the University of Maryland, Baltimore are expanding the research and clinical scope at Cole Field House.

University of Maryland Ranks Among Top 100 Worldwide for Patents

The NAI and IPO have ranked the University of Maryland No. 27 in the world and No. 11 among U.S. public institutions for patents awarded in 2016.

Cellth Systems and University of Maryland Enter License Agreement to Advance New Circulating-Tumor-Cell-Analysis Technology

Cellth Systems has been granted exclusive rights for the commercial development of cell-tethering that allows analysis of circulating tumor cells (CTCs).

IBBR Awarded $6 Million NIH Grant for Structure-Based Design of a Hepatitis C Vaccine

The Institute for Bioscience and Biotechnology Research (IBBR) has been awarded a $6.0 million grant to develop a vaccine to prevent hepatitis C virus.

This startup is developing a vaccine for staph infections

Serenta Biotechnology, which is based in Gaithersburg, is working to build on technology that was effective in animal trials.

BBJ: Startup's Tech Matches Cancer Patients with Chemo, Drugs

A local startup wants to help doctors determine which drugs and chemotherapies will best treat different types of cancer.

University of Maryland, Baltimore and Serenta Team Up to Fight Staph Infections

The University of Maryland, Baltimore (UMB) has granted worldwide, exclusive licensing rights for a new vaccine technology to Serenta Biotechnology, LLC.